Filing Details
- Accession Number:
- 0001181431-13-032913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-05 16:39:36
- Reporting Period:
- 2013-06-03
- Filing Date:
- 2013-06-05
- Accepted Time:
- 2013-06-05 16:39:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1016169 | Antares Pharma Inc. | ATRS | Surgical & Medical Instruments & Apparatus (3841) | 411350192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1054942 | F Robert Apple | C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628 | Executive Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-03 | 86,400 | $0.47 | 455,318 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-03 | 86,400 | $4.01 | 368,918 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-04 | 28,600 | $0.47 | 397,518 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-04 | 28,600 | $4.03 | 368,918 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-06-03 | 86,400 | $0.00 | 86,400 | $0.47 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-06-04 | 28,600 | $0.00 | 28,600 | $0.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,174,282 | 2018-11-12 | No | 4 | M | Direct | |
| 1,145,682 | 2018-11-12 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The options vested in equal quarterly installments over three years following the grant date.
Billionaire Hedge Funds
